Thyrocare Technologies Ltd up by 10.19 percent | Espresso Market Updates

EspressoLogy

Espresso shot of the day – Thyrocare Technologies Ltd up by 10.19 percent

June 11, 2021
Espresso shot of the day – Thyrocare Technologies Ltd up by 10.19 percent

THYROCARE TECHNOLOGIES LTD 1228.85 (+10.19%) BSE – INE594H01019 | 11th JUNE 2021

https://www.myespresso.com/images/Binge-graph-image_Thyrocare-Technologies-LTD-202106111900114298362.jpg

Thyrocare Technologies Limited is India's first and foremost advanced fully automated laboratory with a strong presence in over 2000 cities/towns, both nationally and internationally. Thyrocare Technologies Limited is unique and focuses on providing quality at affordable costs to laboratories and hospitals, endeavouring to supply cost effective and convenient diagnostic services to every single doorstep. The headquarters of Thyrocare Technologies Limited, also known as Centralised Processing Laboratory (CPL) is located at Navi Mumbai, India which conducts esoteric tests. They also have Regional Processing Laboratories (RPLs) situated in major metro cities of India and other parts of Asia. They aim to provide advanced technologies, powerful brands and strong systems that enable all laboratories to give their clients the best of science and technology at an affordable cost. With a belief that 'Quality' is the heart of any intelligent management, Thyrocare Technologies Limited has become one of the first Indian diagnostic laboratories to obtain internationally renowned quality accreditations like ISO 9001-2000 rating as early as 2001, which has now upgraded to ISO 9001:2008 and NABL and CAP (College of American Pathologists) accreditations in 2005.

Recent Drivers

  • On June 11, 2021, Thyrocare Technologies Limited reported quarterly net profit at Rs 37.75 crores in March 2021 up 2459.38% from Rs 1.60 crores in March 2020.
  • On June 11, 2021, Thyrocare Technologies Limited net sales at Rs 146.84 crores in March 2021 up 44.76% from Rs 101.44 crores in March 2020.
  • Thyrocare Technologies Limited is willing to offer RT-PCR testing at Rs 300, as low as antigen test, only for underserved districts and rapid anti gen test will be between Rs150-300.
  • On June 17, 2021, The company has declared final dividend of Rs 15.
(Sources: Moneycontrol, Freepress)

Technical Force*

  • S&P BSE500 month till date gain up by 2.60%
  • Traded on new 52-week-high value of 1244.00
  • 3 months avg. volume of NSE: 4,46,294
  • Quantity traded: 1,29,212 | Deliverable quantity: 47,886 (37.06%)
  • Stock price has jumped more than 150% from one year low level: 485.30 (July 1, 2021)
  • Daily RSI (14) is in Overbought territory today
  • 52-week-high: 1244.00 | 52-week-low: 485.30

Key Pivot  (Yearly)

R4

R3

R2

R1

PP /FIB PP

S1

S2

S3

S4

Pivot Point

-

2082.27

1647.13

1280.27

845.13

478.27

43.13

-

-

Fibonacci Pivot

1647.13

1340.77

1151.50

1029.59

845.13

660.67

538.77

349.50

43.13


Today’s Close

1228.85

SMA

BSE

10 DAY

1091.01

20 DAY

1057.40

50 DAY

1034.66

200 DAY

962.05


Some Key Ratios (Source: BSE)

Market Cap: 6,497.47 crores

PE: 54.25

OPM%: 38.19

ROE%: 26.89

Promoters holding%: 66.14

Prev. Close: 1115.20

*Chart And Technical Force data taken from the Binge desktop app.

The scope and usability of this information/data is time-sensitive and market-based, and as such the same may become outdated for the investment decisions of clients, for which Sharekhan comtrade bears no responsibility. References to securities do not constitute a recommendation to buy, sell or hold such securities. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document and should consult his own advisors to determine the merits and risks of such an investment. Sharekhan Comtrade Private Limited is under no obligation to update the information in this document from time-to-time.



Chandresh Khona
by Chandresh Khona

Product Offerings Head

A teacher, writer, travel buff and now Espresso's Product Offerings Head. Ten years here has allowed me to lead the digital team at Sharekhan. My true passion lies in stock market charts.